PMID- 31985511 OWN - NLM STAT- MEDLINE DCOM- 20210624 LR - 20210624 IS - 1935-3227 (Electronic) IS - 1932-0620 (Linking) VI - 14 IP - 4 DP - 2020 Jul/Aug TI - Trends in Cannabis Treatment Admissions in Adolescents/Young Adults: Analysis of TEDS-A 1992 to 2016. PG - e29-e36 LID - 10.1097/ADM.0000000000000586 [doi] AB - OBJECTIVES: This study aims to evaluate changes in cannabis use patterns, referral sources, and admissions in adolescents and young adults (YAs). As the United States increasingly moves toward liberalization of cannabis laws, it is critical to have baseline information of use patterns in this population. METHODS: Data were drawn from Treatment Episode Data Set-Admissions (TEDS-A) for adolescents (12-17 years) and young adults (18-24 years) entering treatment from 1992 to 2016 for primary cannabis use (N = 3,794,213). Rao-Scott chi-square tests were used to test for significant changes in proportions of individuals admitted to treatment for primary cannabis use and between 4-year increments from 1992 to 2016 (N = 1,052,724). Logistic regression assessed odds of admissions for primary cannabis use versus other substances. RESULTS: Treatment admissions for cannabis among adolescents/YAs rose 3-fold from 1992 (49,996) to 1996 (125,858). The majority of referrals came from the criminal justice system (56%). Cannabis is increasingly the sole substance of use, with polysubstance use decreasing from 89% in 1992 to 59% in 2016. While alcohol-related treatment admissions were most common in 1992, admissions for treatment of cannabis use (followed by heroin and alcohol) were highest (38%) by 2016. Being an adolescent (odds ratio [OR] 3.1, 95% confidence interval [CI] 3.1-3.2), non-Hispanic black (OR 6.2, 95% CI 6.2-6.3), male (female OR 0.6, 95% CI 0.6-0.6) with co-occurring alcohol use (OR 25.9, 95% CI 25.7-26.1) was associated with admission for treatment of primary cannabis use as compared with other substances. CONCLUSIONS: Public health efforts will be needed to ensure ongoing access and referral to treatment as the legal status of cannabis continues to change. Prevention and treatment efforts should target co-occurring alcohol and cannabis use. FAU - Standeven, Lindsay R AU - Standeven LR AD - Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD (LRS, MSC); Obstetrics and Gynecology, Virginia Commonwealth University, Richmond, VA (AS, MT); Psychiatry, Virginia Commonwealth University, Richmond, VA (MT). FAU - Scialli, Anna AU - Scialli A FAU - Chisolm, Margaret S AU - Chisolm MS FAU - Terplan, Mishka AU - Terplan M LA - eng PT - Journal Article PL - Netherlands TA - J Addict Med JT - Journal of addiction medicine JID - 101306759 RN - 0 (Medical Marijuana) SB - IM MH - Adolescent MH - Alcohol Drinking MH - *Cannabis MH - Female MH - Hospitalization MH - Humans MH - Male MH - *Medical Marijuana MH - *Substance-Related Disorders MH - United States/epidemiology MH - Young Adult EDAT- 2020/01/28 06:00 MHDA- 2021/06/25 06:00 CRDT- 2020/01/28 06:00 PHST- 2020/01/28 06:00 [pubmed] PHST- 2021/06/25 06:00 [medline] PHST- 2020/01/28 06:00 [entrez] AID - 10.1097/ADM.0000000000000586 [doi] PST - ppublish SO - J Addict Med. 2020 Jul/Aug;14(4):e29-e36. doi: 10.1097/ADM.0000000000000586.